does semaglutide cause heartburn and indigestion Can Acid Reflux? Symptoms Management acid reflux on semaglutide side

Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease

All content is strictly informational and should not be considered medical advice

Injectable tirzepatide (Mounjaro) reaches roughly 22.5% at its top dose, and injectable semaglutide (Wegovy) around 15% at 2.4 mg

This ensures that semaglutide is appropriate for your specific metabolic profile